137 related articles for article (PubMed ID: 34585409)
1. Crataegus aronia prevents high-fat diet-induced hepatic steatosis in rats by activating AMPK-induced suppression of SREBP1 and activation of PPARα.
Shatoor AS; Al Humayed S; Almohiy HM
J Food Biochem; 2021 Nov; 45(11):e13945. PubMed ID: 34585409
[TBL] [Abstract][Full Text] [Related]
2. Crataegus aronia enhances sperm parameters and preserves testicular architecture in both control and non-alcoholic fatty liver disease-induced rats.
Dallak M
Pharm Biol; 2018 Dec; 56(1):535-547. PubMed ID: 30375253
[TBL] [Abstract][Full Text] [Related]
3. Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats.
Almohawes ZN; El-Kott A; Morsy K; Shati AA; El-Kenawy AE; Khalifa HS; Elsaid FG; Abd-Lateif AM; Abu-Zaiton A; Ebealy ER; Abdel-Daim MM; Ghanem RA; Abd-Ella EM
Arch Physiol Biochem; 2024 Jun; 130(3):257-274. PubMed ID: 35061559
[TBL] [Abstract][Full Text] [Related]
4. The Protective Effect of Crataegus aronia Against High-Fat Diet-Induced Vascular Inflammation in Rats Entails Inhibition of the NLRP-3 Inflammasome Pathway.
Shatoor AS; Al Humayed S
Cardiovasc Toxicol; 2020 Feb; 20(1):82-99. PubMed ID: 31183600
[TBL] [Abstract][Full Text] [Related]
5. Crataegus Aronia protects and reverses vascular inflammation in a high fat diet rat model by an antioxidant mechanism and modulating serum levels of oxidized low-density lipoprotein.
Shatoor AS; Al Humayed S; Alkhateeb MA; Shatoor KA; Aldera H; Alassiri M; Shati AA
Pharm Biol; 2019 Dec; 57(1):38-48. PubMed ID: 30702358
[TBL] [Abstract][Full Text] [Related]
6. Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK.
Mohammed HM
J Food Biochem; 2022 Jul; 46(7):e14149. PubMed ID: 35338494
[TBL] [Abstract][Full Text] [Related]
7. Protective and therapeutic effects of Crataegus aronia in non-alcoholic fatty liver disease.
Al Humayed S
Arch Physiol Biochem; 2017 Feb; 123(1):23-30. PubMed ID: 27424611
[TBL] [Abstract][Full Text] [Related]
8. The hypocoagulant effect of Crataegus aronia in rats entails vitamin K-dependent and vitamin K-independent effects.
Shatoor AS; Shati A; Al Humayed SM; Shatoor AK; Alhawiti NM; Alqahtani SA
J Food Biochem; 2020 Jan; 44(1):e13094. PubMed ID: 31702060
[TBL] [Abstract][Full Text] [Related]
9. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.
Bian Y; Li X; Li X; Ju J; Liang H; Hu X; Dong L; Wang N; Li J; Zhang Y; Yang B
Biomed Pharmacother; 2019 Sep; 117():109176. PubMed ID: 31387185
[TBL] [Abstract][Full Text] [Related]
10. Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways.
Yasmin T; Rahman MM; Khan F; Kabir F; Nahar K; Lasker S; Islam MD; Hossain MM; Hasan R; Rana S; Alam MA
Biochem Biophys Rep; 2021 Dec; 28():101168. PubMed ID: 34825068
[TBL] [Abstract][Full Text] [Related]
11. Liquorice root extract and isoliquiritigenin attenuate high-fat diet-induced hepatic steatosis and damage in rats by regulating AMPK.
Yahya MA; Alshammari GM; Osman MA; Al-Harbi LN; Yagoub AEA; AlSedairy SA
Arch Physiol Biochem; 2022 Sep; ():1-16. PubMed ID: 36121371
[No Abstract] [Full Text] [Related]
12. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
13. Taurine prevents high-fat diet-induced-hepatic steatosis in rats by direct inhibition of hepatic sterol regulatory element-binding proteins and activation of AMPK.
Morsy MD; Aboonq MS; ALsleem MA; Abusham AA
Clin Exp Pharmacol Physiol; 2021 Jan; 48(1):72-85. PubMed ID: 32691860
[TBL] [Abstract][Full Text] [Related]
14. Metformin mitigates renal dysfunction in obese insulin-resistant rats via activation of the AMPK/PPARα pathway.
Thongnak L; Pengrattanachot N; Promsan S; Phengpol N; Sutthasupha P; Jaikumkao K; Lungkaphin A
Arch Pharm Res; 2023 May; 46(5):408-422. PubMed ID: 36966452
[TBL] [Abstract][Full Text] [Related]
15. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats.
Liu H; Zhong H; Yin Y; Jiang Z
Biomed Pharmacother; 2017 Jul; 91():964-969. PubMed ID: 28514835
[TBL] [Abstract][Full Text] [Related]
16. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
17. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
18. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
[TBL] [Abstract][Full Text] [Related]
19. Activation of AMPK Entails the Protective Effect of Royal Jelly against High-Fat-Diet-Induced Hyperglycemia, Hyperlipidemia, and Non-Alcoholic Fatty Liver Disease in Rats.
Felemban AH; Alshammari GM; Yagoub AEA; Al-Harbi LN; Alhussain MH; Yahya MA
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986201
[TBL] [Abstract][Full Text] [Related]
20. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
